Chitosans for gene delivery

被引:445
作者
Borchard, G [1 ]
机构
[1] Leiden Amsterdam Ctr Drug Res, Div Pharmaceut Technol, NL-2300 RA Leiden, Netherlands
关键词
chitosan; non-viral gene delivery; transfection;
D O I
10.1016/S0169-409X(01)00198-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Efficient non-viral gene delivery based on cationic polymers as DNA-condensing agents is dependent on a variety of factors, e.g. complex size, complex stability, toxicity, immunogenicity, protection against DNase degradation, and intracellular trafficking and processing of the DNA. This review examines the advances in the application of chitosan and chitosan derivatives to non-viral gene delivery, and gives an overview of transfection studies which have been performed recently using chitosans as transfection agents. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:145 / 150
页数:6
相关论文
共 31 条
[1]  
[Anonymous], P INT S CONTR REL BI
[2]   QUANTITATIVE-DETERMINATION OF CHITOSAN AND THE PERCENTAGE OF FREE AMINO-GROUPS [J].
CUROTTO, E ;
AROS, F .
ANALYTICAL BIOCHEMISTRY, 1993, 211 (02) :240-241
[3]   Cationic polymer based gene delivery systems [J].
De Smedt, SC ;
Demeester, J ;
Hennink, WE .
PHARMACEUTICAL RESEARCH, 2000, 17 (02) :113-126
[4]  
Delie F, 1997, CRIT REV THER DRUG, V14, P221
[5]   Target specific optimization of cationic lipid-based systems for pulmonary gene therapy [J].
Deshpande, D ;
Blezinger, P ;
Pillai, R ;
Duguid, J ;
Freimark, B ;
Rolland, A .
PHARMACEUTICAL RESEARCH, 1998, 15 (09) :1340-1347
[6]   Chitosan-based vector/DNA complexes for gene delivery: Biophysical characteristics and transfection ability [J].
Erbacher, P ;
Zou, SM ;
Bettinger, T ;
Steffan, AM ;
Remy, JS .
PHARMACEUTICAL RESEARCH, 1998, 15 (09) :1332-1339
[7]  
Garnett MC, 1999, CRIT REV THER DRUG, V16, P147
[8]   GENE-THERAPY FOR CYSTIC-FIBROSIS [J].
GEDDES, DM ;
ALTON, EWFW .
NETHERLANDS JOURNAL OF MEDICINE, 1995, 46 (06) :306-313
[9]  
Hirano S., 1988, POLYM ENG SCI, V59, P897
[10]  
KADIYALA I, 2000, P INT S CONTROL REL, V27, P117